FirsthandHealth
medRxiv PreprintsInternational11 November 2026

Pooled Multiplex Amplicon Massive Parallel Sequencing for High-Throughput Confirmation of Whole-Genome Sequencing Potentially Pathogenic Variants in Patients with Parkinsonism

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Whole-genome sequencing identifies large numbers of genetic variants, although only a subset requires independent confirmation for clinical interpretation. Sanger sequencing remains the standard confirmation method but is impractical for large-scale variant verification. We developed and evaluated a strategy for variant confirmation based on multi-amplicon massively parallel sequencing of pooled DNA samples. Whole-genome sequencing data were obtained from 86 individuals, including patients with parkinsonism and controls. Variants were selected using phenotype-driven filtering, ClinVar classifi
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.